Transcription Factor |
Target ORF/Genes |
References |
Evidence Code |
Evidence Experiment |
Association Type |
Strain |
Environmental Condition |
Gln3p
|
YNL142W
|
PubMed
Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93Marini AM et al., Mol Cell Biol, 1997 Aug;17(8):4282-93 |
Indirect |
lacZ - wt vs TF mutant |
Positive |
S288c |
0,1% Glutamine (nitrogen source) |
PubMed
Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81Shamji AF et al., Curr Biol, 2000 Dec 14-28;10(24):1574-81 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
S288c |
30 min 50 nM treatment with rapamycin in YPD |
PubMed
Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104Harbison CT et al., Nature, 2004 Sep 2;431(7004):99-104 |
Direct |
Chip-on-chip |
N/A |
S288c |
N/A |
PubMed
Hirasaki M et al., Gene, 2008;():Hirasaki M et al., Gene, 2008;(): |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
S288c |
YPAD + 14mM Caffeine 1h |
PubMed
Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911Staschke KA et al., J Biol Chem, 2010 May 28;285(22):16893-911 |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn2DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgcn4DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
Indirect |
Microarray analysis - wt vs TF mutant |
Positive |
EG328-1A |
RNA prepared from wt and DELTAgln3 cells treated for 1 h with 200 nM Rapamycin |
PubMed
Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87Fayyadkazan M et al., Microbiologyopen, 2014 Jun;3(3):271-87 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
S288c |
cells grown in YPD medium and then treated with rapamycin o transferred to proline medium. |
PubMed
Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7Numamoto M et al., J Biosci Bioeng, 2015 Aug;120(2):121-7 |
Indirect |
RT-PCR - wt vs TF mutant |
Positive |
S288c |
DELTAgln3 carrying or not a plasmid pRS316-GLN3S391D-Myc13 incubated in YPDA medium, supplemented with 5 mM caffeine for 30 min |